MDMA Statement on House Ways and Means Committee Vote on Medical Device Tax Repeal
Thursday, May 31, 2012
WASHINGTON, DC – Mark
Leahey, President and CEO of the Medical Device Manufacturers
Association (MDMA), issued the following statement today regarding the
House Ways and Means Committee vote on H.R. 436, the "Protect Medical
Innovation Act of 2011:"
"Today marks the first step
towards repealing the 2.3 percent device tax, and we thank Congressman
Erik Paulsen and all Members of Congress who are fighting on behalf of
medical technologies and patient care.
long said that the device tax would hamper job creation and unfairly
punish the dynamic American success story that is medical technology
innovation. The growing price tag of this onerous tax is further proof
that it will lead to more layoffs, larger cuts to R&D and less innovation – a perfect storm of unintended consequences.
"This issue not only impacts one of
the United States’ most innovative industries, but is a perfect
opportunity for Congress to work in a bipartisan manner to support the
common goal of renewed job creation.
"MDMA is committed to working with
Members of both parties and both Chambers to help ensure that this
misguided policy is repealed. Simply put, the medical device tax will
hurt manufacturing, stymie job growth and impede patient care, all at a
time when we can least afford it.”